- Home
- CRDF vs USAS Comparison
CRDF vs USAS Comparison
Compare CRDF & USAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- USAS
- Stock Information
- Founded
- CRDF 1999
- USAS 1998
- Country
- CRDF United States
- USAS Canada
- Employees
- CRDF N/A
- USAS N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- USAS Metal Mining
- Sector
- CRDF Health Care
- USAS Basic Materials
- Exchange
- CRDF Nasdaq
- USAS Nasdaq
- Market Cap
- CRDF 288.7M
- USAS 286.7M
- IPO Year
- CRDF N/A
- USAS N/A
- Fundamental
- Price
- CRDF $3.73
- USAS $0.57
- Analyst Decision
- CRDF Strong Buy
- USAS Strong Buy
- Analyst Count
- CRDF 4
- USAS 1
- Target Price
- CRDF $12.00
- USAS $0.90
- AVG Volume (30 Days)
- CRDF 1.2M
- USAS 891.9K
- Earning Date
- CRDF 05-01-2025
- USAS 05-14-2025
- Dividend Yield
- CRDF N/A
- USAS N/A
- EPS Growth
- CRDF N/A
- USAS N/A
- EPS
- CRDF N/A
- USAS N/A
- Revenue
- CRDF $683,000.00
- USAS $97,123,000.00
- Revenue This Year
- CRDF N/A
- USAS $21.84
- Revenue Next Year
- CRDF N/A
- USAS $46.00
- P/E Ratio
- CRDF N/A
- USAS N/A
- Revenue Growth
- CRDF 39.96
- USAS 14.33
- 52 Week Low
- CRDF $2.01
- USAS $0.20
- 52 Week High
- CRDF $6.38
- USAS $0.60
- Technical
- Relative Strength Index (RSI)
- CRDF 45.87
- USAS 57.16
- Support Level
- CRDF $3.65
- USAS $0.45
- Resistance Level
- CRDF $3.88
- USAS $0.56
- Average True Range (ATR)
- CRDF 0.26
- USAS 0.04
- MACD
- CRDF -0.02
- USAS 0.01
- Stochastic Oscillator
- CRDF 30.00
- USAS 76.21
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.